Abnormal expression of HDAC9 has been found in a variety of tumors; overexpression of HDAC9 is associated with poor prognosis for patients with breast cancer [13], glioblastoma [14], and non-small cell lung cancer [15]. Here, HDAC9 is linked to glioblastoma.